August 26, 2020 — The global pediatric imaging market size is expected to reach $12.2 billion by 2027, registering a CAGR of 7.6% over the forecast period, according to a new report by Grand View Research, Inc. Increasing incidences of pediatric trauma cases are expected to accelerate the demand for innovative patient screening, which is expected to augment the market growth.
According to the Centers for Disease Control and Prevention (CDC), an estimated 812,000 children aged 17 or below were treated in the emergency department (ED) for concussion or traumatic brain injury (TBI) in 2014. CDC further stated that injuries due to falling accounted for an approximate 49% of all TBI-related ED visits in children. In addition, increasing focus of market players on product development and innovation is expected to drive the market growth. For instance, in June 2019, Carestream Health, Inc. launched a portable Carestream DRX Plus 2530C X-ray detector with cesium iodide technology, which captures minute details of anatomical structures in pediatric patients.
North America accounted for the largest share in 2019 owing to favorable reimbursement policies, faster adoption of innovative imaging modalities, and growing consumer preference toward noninvasive diagnosis. Increasing investments in order to propel technological innovation is expected to augment the pediatric imaging market growth in the region. For instance, in 2018, Bracco Diagnostics Inc. provided a grant of USD 300,000 to Children's Hospital of Philadelphia (CHOP), to fund research and train technicians to use a new technology of contrast ultrasound. Also, medical coverage is granted by the Children's Health Insurance Program (CHIP) for pediatric patients in U.S., which covers imaging services, is a major factor propelling the market growth.
For more information: www.grandviewresearch.com/industry-analysis/pediatric-imaging-market